Literature DB >> 22783420

CD99-positive soft tissue sarcoma with chromosomal translocation between 1 and 16 and inversion of chromosome 5.

Masahiko Kanamori1, Kayo Suzuki, Taketoshi Yasuda, Takeshi Hori.   

Abstract

In this study, we report the cytogenetic analysis of a 31-year-old male with a rare translocation between chromosomes 1 and 16 and inversion of chromosome 5 in CD99-positive soft tissue sarcoma of the thigh, which metastasized to the lung. Histologically, the tumor showed ovoid or short-spindle atypical cells with positivities of CD99, vimentin and bcl-2. Cytogenetically, all 20 analyzed cells showed the clonal aberrations add(1)(q23), t(1;16)(p21;p11.2), inv(5)(q11.2;q15). This finding adds to the new karyotype spectrum of CD99-positive soft tissue sarcomas.

Entities:  

Year:  2012        PMID: 22783420      PMCID: PMC3392573          DOI: 10.3892/ol.2012.641

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  7 in total

1.  Clonal chromosomal abnormalities in desmoid tumors. Implications for histopathogenesis.

Authors:  J A Bridge; C Sreekantaiah; B Mouron; J R Neff; A A Sandberg; S R Wolman
Journal:  Cancer       Date:  1992-01-15       Impact factor: 6.860

2.  CD99-positive large cell neuroendocrine carcinoma with rearranged EWSR1 gene in an infant: a case of prognostically favorable tumor.

Authors:  Vicki S Malone; Sheila M Dobin; Kathleen A Jones; Ludvik R Donner
Journal:  Virchows Arch       Date:  2010-07-09       Impact factor: 4.064

3.  Response to mesna, doxorubicin, ifosfamide, and dacarbazine in 108 patients with metastatic or unresectable sarcoma and no prior chemotherapy.

Authors:  A Elias; L Ryan; A Sulkes; J Collins; J Aisner; K H Antman
Journal:  J Clin Oncol       Date:  1989-09       Impact factor: 44.544

4.  Multiple chromosomal mechanisms generate an EWS/FLI1 or an EWS/ERG fusion gene in Ewing tumors.

Authors:  C Desmaze; F Brizard; C Turc-Carel; T Melot; O Delattre; G Thomas; A Aurias
Journal:  Cancer Genet Cytogenet       Date:  1997-08

5.  CD99 inhibits neural differentiation of human Ewing sarcoma cells and thereby contributes to oncogenesis.

Authors:  Anna Rocchi; Maria Cristina Manara; Marika Sciandra; Diana Zambelli; Filippo Nardi; Giordano Nicoletti; Cecilia Garofalo; Stefania Meschini; Annalisa Astolfi; Mario P Colombo; Stephen L Lessnick; Piero Picci; Katia Scotlandi
Journal:  J Clin Invest       Date:  2010-02-08       Impact factor: 14.808

6.  Translocation-positive low-grade fibromyxoid sarcoma: clinicopathologic and molecular analysis of a series expanding the morphologic spectrum and suggesting potential relationship to sclerosing epithelioid fibrosarcoma: a study from the French Sarcoma Group.

Authors:  Louis Guillou; Jean Benhattar; Carole Gengler; Gabrielle Gallagher; Dominique Ranchère-Vince; Françoise Collin; Philippe Terrier; Marie-José Terrier-Lacombe; Agnès Leroux; Bernard Marquès; Nicolas de Saint Aubain Somerhausen; Frédérique Keslair; Florence Pedeutour; Jean-Michel Coindre
Journal:  Am J Surg Pathol       Date:  2007-09       Impact factor: 6.394

7.  Combinatorial generation of variable fusion proteins in the Ewing family of tumours.

Authors:  J Zucman; T Melot; C Desmaze; J Ghysdael; B Plougastel; M Peter; J M Zucker; T J Triche; D Sheer; C Turc-Carel
Journal:  EMBO J       Date:  1993-12       Impact factor: 11.598

  7 in total
  3 in total

Review 1.  Extracranial medulloepithelioma: a review of the literature.

Authors:  David Bailey; Christine Mau; Christina Toepke; Elizabeth Finch; Elias Rizk
Journal:  Childs Nerv Syst       Date:  2022-04-27       Impact factor: 1.532

2.  Radiological and pathological diagnosis of an incidental Askin tumor.

Authors:  Brian Covello; Steven Hartman; Sean Kaufman; Orlando Enrizo
Journal:  Radiol Case Rep       Date:  2021-03-27

Review 3.  The dual role of tumor lymphatic vessels in dissemination of metastases and immune response development.

Authors:  Joanna Stachura; Malgorzata Wachowska; Witold W Kilarski; Esra Güç; Jakub Golab; Angelika Muchowicz
Journal:  Oncoimmunology       Date:  2016-05-13       Impact factor: 8.110

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.